Hyundai Bioscience Co., Ltd. Stock price

Equities

A048410

KR7048410005

Personal Products

End-of-day quote Korea Stock Exchange 06:00:00 2023-11-28 pm EST Intraday chart for Hyundai Bioscience Co., Ltd. 5-day change 1st Jan Change
28,900.00 KRW -2.53% -6.17% +5.47%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
Sales 2022 7,852 M 6.05 M Sales 2023 * - Capitalization 1,087 B 837 M
Net income 2022 -15.81 B -12.17 M Net income 2023 * - EV / Sales 2022
137x
Net cash position 2022 12.48 B 9.61 M Net cash position 2023 * - 0 EV / Sales 2023 * -
P/E ratio 2022
-68,2x
P/E ratio 2023 *
Employees 63
Yield 2022
-
Yield 2023 *
-
Free-Float 87.06%
More Fundamentals * Assessed data
Dynamic Chart
Hyundai Bioscience Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Vector Inc. completed the acquisition of additional 25.071429% stake in Vitabrid Japan Inc. from Hyundai Bioscience Co., Ltd. CI
Hyundai Bioscience Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Hyundai Bioscience Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Hyundai Bioscience Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Vector Inc. agreed to acquire additional 25.071429% stake in Vitabrid Japan Inc. from Hyundai Bioscience Co., Ltd. for KRW 13.7 billion. CI
Hyundai Bioscience to request a fast track processing for its monkeypox treatment drug with the FDA CI
Hyundai Bioscience Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Hyundai Bioscience Co., Ltd. Launches CP-COV03 Phase 2 Clinical Trials CI
Hyundai Bioscience Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
South Korean Pharmaceutical Firms Rush to Develop COVID-19 Oral Pills MT
Hyundai Bioscience Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Hyundai Bioscience Co., Ltd. Announces Oral Antiviral Drug from Korea May Be A Problem Solver for Covid-19 CI
Hyundai Bioscience Announces CNPharm Publishes a Research Paper on Successful Repurposing of Niclosamide for COVID-19 Treatment by Using a Drug Delivery System CI
Hyundai Bioscience Develops Injection Drug for Potential Treatment of Severe Cases of COVID-19 CI
More news
1 day-2.53%
1 week-6.17%
Current month-22.73%
1 month-25.23%
3 months+5.09%
6 months+27.88%
Current year+5.47%
More quotes
1 week
28 500.00
Extreme 28500
30 950.00
1 month
28 500.00
Extreme 28500
40 550.00
Current year
18 740.00
Extreme 18740
41 200.00
1 year
18 740.00
Extreme 18740
41 200.00
3 years
10 400.00
Extreme 10400
66 300.00
5 years
4 925.00
Extreme 4925
66 300.00
10 years
1 245.00
Extreme 1245
66 300.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 2013
Chief Tech/Sci/R&D Officer 49 -
Director/Board Member 59 2015
Members of the board TitleAgeSince
Chief Executive Officer 64 2013
Director/Board Member 56 -
Director/Board Member 59 2015
More insiders
Date Price Change Volume
23-11-30 29,050.00 +0.52% 382,169
23-11-29 28,900.00 -2.53% 556,217
23-11-28 29,650.00 -3.42% 460,616
23-11-27 30,700.00 +4.24% 586,693
23-11-24 29,450.00 -0.34% 579,900

End-of-day quote Korea Stock Exchange, November 28, 2023

More quotes
HYUNDAI BIOSCIENCE CO., LTD. it is a Korea-based company mainly engaged in the manufacturing and sale of bio cosmetics and hair tonic products. It develops functional daily necessities such as shampoos, mask packs, creams, and tumor-targeted drug. The Company also sells liquid crystal display (LCD) monitors and digital signage display products. The Company distributes its products in domestic market, as well as to the overseas markets, including Europe, America and Japan.
More about the company
1st Jan change Capi. (M$)
+5.47% 890 M $
-10.37% 119 B $
-1.39% 71 166 M $
-1.15% 64 124 M $
-49.38% 44 946 M $
0.00% 38 453 M $
+20.24% 32 127 M $
-3.84% 17 838 M $
+15.35% 12 287 M $
-4.17% 11 368 M $
Other Personal Products
  1. Stock
  2. Equities
  3. Stock Hyundai Bioscience Co., Ltd. - Korea Stock Exchange
-40% off Black Friday : Our subscriptions help you unlock the best investment opportunities.
Enjoy this offer